Search clinical trials for: Lantus followed by Gan & Lee insulin glargine
Total 245 results
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1United States
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Spain, United States, Germany, Czechia, Hungary, Poland
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 2United States
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Germany
-
Tamra DukatzSanofiCompleted
-
Indonesia UniversityCompletedDiabetes MellitusIndonesia
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
SanofiCompleted
-
Lannett Company, Inc.Parexel; FARMOVS (Pty) LtdCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusSouth Africa
-
SanofiCompleted
-
Ruhr University of BochumCompleted
-
SanofiCompleted
-
University of AlbertaSanofiCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
RISE Study GroupNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Emory UniversitySanofiCompletedDiabetes MellitusUnited States
-
SanofiCompleted
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompleted
-
SanofiCompletedType 1 Diabetes MellitusJapan
-
University of Colorado, DenverSanofiCompleted
-
Joslin Diabetes CenterSanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Mylan Inc.Mylan GmbHCompletedType 1 Diabetes MellitusCzechia, United States, Canada, Estonia, Germany, Hungary, Latvia, Slovakia
-
Mylan Inc.Mylan GmbHCompletedType 1 DiabetesUnited States, Canada, Czechia, Estonia, Germany, Hungary, Latvia, Romania, Slovakia, South Africa, United Kingdom
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
SanofiCompletedType 2 DiabetesFrance
-
Skane University HospitalMedical Research Council; Skane County Council Research & Development FoundationCompletedType 2 Diabetes | Secondary Drug FailureSweden
-
SanofiCompleted
-
Mylan Inc.Mylan GmbHCompletedType 2 DiabetesUnited States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
-
Northwestern UniversitySanofiCompletedHyperglycemia | DiabetesUnited States
-
SanofiCompletedType 1 Diabetes MellitusUnited States
-
Massachusetts General HospitalSanofiCompletedType 1 Diabetes | Dawn PhenomenonUnited States
-
Johns Hopkins UniversityTerminatedHypoglycemia | Type 1 DiabetesUnited States
-
Merck Sharp & Dohme LLCCompleted
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
LMC Diabetes & Endocrinology Ltd.CompletedDiabetes Mellitus, Type 2Canada
-
GeropharmCompletedClamp StudyRussian Federation
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Completed
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
Medical University of ViennaCompletedType 2 Diabetes MellitusAustria
-
University of PadovaCompletedCardiovascular Disease | Type 2 Diabetes | Endothelial DysfunctionItaly
-
Munich Municipal HospitalAventis PharmaceuticalsUnknownCoronary Artery Disease | Type 2 DiabetesGermany
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
SanofiCompleted